<div id="subtitle">Geron reports anticancer activity in preclinical study on developing drug imetelstat</div><div><p>Biotechnology company Geron Corp. said Tuesday its developing stem-cell technology inhibited tumor activity and reduced tumor size in a laboratory study focusing on the most common form of brain cancer.</p><p ...

<div id="subtitle">Geron's developing cancer treatment meets midstage study goals</div><div><p>Biotechnology company Geron Corp. said Tuesday its developing cancer treatment GRNVAC1 met safety and tolerability goals in a midstage study.</p><p>The drug candidate is actually a developing vaccine, aimed at prompting ...

<div><p>BANGALORE (Reuters) - Geron Corp said animals injected with its experimental cell therapy for subacute spinal cord injury developed microscopic cysts in the injury site, but its shares rose as the company reported none of the animals developed teratomas, a kind of tumor.</p><p>Shares of the stem cell research ...